Method of Producing Optically Active 4-Amino-3-Substituted Phenylbutanoic Acid
    21.
    发明申请
    Method of Producing Optically Active 4-Amino-3-Substituted Phenylbutanoic Acid 有权
    生产光学活性4-氨基-3-取代苯基丁酸的方法

    公开(公告)号:US20090137819A1

    公开(公告)日:2009-05-28

    申请号:US12086056

    申请日:2006-12-08

    IPC分类号: C07D207/12 C07C69/612

    摘要: The present invention provides a method of producing a compound (IIa) or a compound (IIb), provides a method of producing a compound (IIIa) or a compound (IIIb), provides a method of producing a compound (Va) or its salt or a compound (Vb) or its salt, provides a method of producing a compound (IIIa) or a compound (IIIb), further, provides a method of producing a compound (Va) or its salt or a compound (Vb) or its salt including these production methods.

    摘要翻译: 本发明提供化合物(IIa)或化合物(IIb)的制造方法,提供化合物(IIIa)或化合物(IIIb)的制造方法,提供化合物(Va)或其盐 或化合物(Vb)或其盐,提供化合物(IIIa)或化合物(IIIb)的制造方法,进一步提供化合物(Va)或其盐或化合物(Vb)或其化合物 盐包括这些生产方法。

    Tricarboxylic acid-containing oxyalkyl esters and uses thereof
    25.
    发明授权
    Tricarboxylic acid-containing oxyalkyl esters and uses thereof 失效
    含三羧酸的烷氧基酯及其用途

    公开(公告)号:US6130248A

    公开(公告)日:2000-10-10

    申请号:US781905

    申请日:1996-12-30

    摘要: This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, augmenting expression of a tumor suppressor gene and inducing tolerance to an antigen. The methods of the invention use tricarboxylic acid substituted oxyalkyl esters.

    摘要翻译: 本发明涉及治疗,预防或改善癌症和其它增殖性疾病的组合物和方法,以及诱导伤口愈合,治疗皮肤溃疡,治疗胃肠道疾病,治疗血液病症如贫血,免疫调节,增强重组基因表达的方法, 治疗胰岛素依赖患者,治疗囊性纤维化患者,抑制端粒酶活性,治疗病毒相关肿瘤,特别是EBV相关肿瘤,增加肿瘤抑制基因的表达并诱导对抗原的耐受性。 本发明的方法使用三羧酸取代的氧烷基酯。

    Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic
acid useful in the treatment of various disorders
    28.
    发明授权
    Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in the treatment of various disorders 有权
    苯基链烷酸和苯基链烯酸的甘油三酯和乙酯可用于治疗各种疾病

    公开(公告)号:US6060510A

    公开(公告)日:2000-05-09

    申请号:US317901

    申请日:1999-05-25

    申请人: Saul W. Brusilow

    发明人: Saul W. Brusilow

    摘要: Two new forms of prodrug for phenylacetate, of even congeners of phenylalkanoic acid and phenylalkenoic acids, which are the phenylalkanoic or phenylalkenoic esters of glycerol, or the ethyl esters of phenylalkanoic acid or phenylalkenoic acids. These forms of the drugs provide a convenient dosage form of the drugs. The prodrugs of the invention are useful to treat patients with diseases of nitrogen accumulation, patients with certain .beta.-hemoglobinopathies, anemia, and cancer.

    摘要翻译: 苯乙酸酯的两种新形式的前药,甚至是苯基链烷酸和苯基链烯酸的同系物,它们是甘油的苯基链烷酸或苯基链烯酸酯,或苯基链烷酸或苯基链烯酸的乙基酯。 这些形式的药物提供了方便的药物剂型。 本发明的前药可用于治疗患有氮积聚疾病,具有某些β-血红蛋白病,贫血和癌症的患者。

    Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic
acid useful in treatment of various disorders
    29.
    发明授权
    Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders 失效
    用于治疗各种疾病的苯基链烷酸和苯基链烯酸的甘油三酯和乙酯

    公开(公告)号:US5968979A

    公开(公告)日:1999-10-19

    申请号:US6432

    申请日:1998-01-13

    申请人: Saul W. Brusilow

    发明人: Saul W. Brusilow

    摘要: Two new forms of prodrug for phenylacetate, of even congeners of phenylalkanoic acid and phenylalkenoic acids, which are the phenylalkanoic or phenylalkenoic esters of glycerol, or the ethyl esters of phenylalkanoic acid or phenylalkenoic acids. These forms of the drugs provide a convenient dosage form of the drugs. The prodrugs of the invention are useful to treat patients with diseases of nitrogen accumulation, patients with certain .beta.-hemoglobinopathies, anemia, and cancer.

    摘要翻译: 苯乙酸酯的两种新形式的前药,甚至是苯基链烷酸和苯基链烯酸的同系物,它们是甘油的苯基链烷酸或苯基链烯酸酯,或苯基链烷酸或苯基链烯酸的乙基酯。 这些形式的药物提供了方便的药物剂型。 本发明的前药可用于治疗患有氮积聚疾病,具有某些β-血红蛋白病,贫血和癌症的患者。

    Process for the preparation of enantiomerically pure cycloalkano-indol
-and azaindol -and pyrimido �1,2a! indolcarboxcyclic acids and their
activated derivatives
    30.
    发明授权
    Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido �1,2a! indolcarboxcyclic acids and their activated derivatives 失效
    制备对映异构纯的环烷基 - 吲哚 - 和氮杂吲哚和嘧啶并[1,2a]吲哚羧酸及其活化衍生物的方法

    公开(公告)号:US5952498A

    公开(公告)日:1999-09-14

    申请号:US829566

    申请日:1997-03-31

    摘要: The invention relates to a process and intermediates for the preparation of enantiomerically pure cycloalkanoindolecarboxylic acids and azaindolecarboxylic acids and pyrimido�1,2a!indolecarboxylic acids and their activated derivatives, characterized in that the tolyl acetic acid is first esterified with a chiral alcohol, then diastereoselective substitution at .alpha.-carbon atoms is carried out and this product is halogenated in the tolyl group and then reacted with appropriate cycloalkanoindoles, cycloalkanoazaindoles or pyrimido�1,2a!indoles. It is possible by this method to prepare specifically, in high purity, the enantiomerically pure carboxylic acids which are intermediates for valuable medicaments.

    摘要翻译: 本发明涉及制备对映体纯的环烷基吲哚羧酸和氮杂吲哚羧酸和嘧啶并[1,2a]吲哚羧酸及其活化衍生物的方法和中间体,其特征在于首先用手性醇酯化甲苯基乙酸,然后进行非对映选择性 在α-碳原子上进行取代,将该产物在甲苯基中卤化,然后与合适的环亚烷基吲哚,环烷基烷基偶氮或嘧啶并[1,2a]吲哚反应。 通过该方法可以高纯度地制备作为有价值药物的中间体的对映体纯的羧酸。